This document is a publication of a European Patent Office (EPO) patent application, EP2026030212A1, titled "GLUCAGON-LIKE PEPTIDE-1 (GLP1) RECEPTOR LIGANDS FOR THE DELIVERY OF THERAPEUTIC AGENTS TO CARDIOMYOCYTES". The publication date is March 18, 2026. It includes several International Patent Classification (IPC) codes related to chemical compounds and their use in medicine, specifically C07D, A61K, and C12N.

As this is a patent application publication, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. It represents a disclosure of an invention for which patent protection is sought. Companies in the pharmaceutical and biotechnology sectors may wish to review this application for competitive intelligence or potential licensing opportunities. The designated states indicate where patent protection is sought within Europe.